8/26/2013

Lupin Pharmaceuticals received federal approval for its rifampin capsules for the treatment of tuberculosis in two strengths: 150 mg and 300 mg. The drug is a generic equivalent of Rifadin by Sanofi Aventis.

Related Summaries